SCHOTT Pharma AG & Co KgaA
XETRA:1SXP

Watchlist Manager
SCHOTT Pharma AG & Co KgaA Logo
SCHOTT Pharma AG & Co KgaA
XETRA:1SXP
Watchlist
Price: 24.76 EUR 1.81% Market Closed
Market Cap: 3.7B EUR
Have any thoughts about
SCHOTT Pharma AG & Co KgaA?
Write Note

Intrinsic Value

The intrinsic value of one 1SXP stock under the Base Case scenario is 32.11 EUR. Compared to the current market price of 24.76 EUR, SCHOTT Pharma AG & Co KgaA is Undervalued by 23%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

1SXP Intrinsic Value
32.11 EUR
Undervaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
SCHOTT Pharma AG & Co KgaA

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
1SXP
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for 1SXP cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about 1SXP?
Bearish
Neutral
Bullish

Fundamental Analysis

24.76 EUR
+1.81%
+1.81%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

SCHOTT Pharma AG & Co KgaA
DE
Life Sciences Tools & Services
Market Cap
3.7B EUR
IPO
Sep 28, 2023
Employees
-
Germany
Market Cap
3.7B EUR
Industry
Life Sciences Tools & Services
IPO
Sep 28, 2023
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about SCHOTT Pharma AG & Co KgaA

Provide an overview of the primary business activities
of SCHOTT Pharma AG & Co KgaA.

What unique competitive advantages
does SCHOTT Pharma AG & Co KgaA hold over its rivals?

What risks and challenges
does SCHOTT Pharma AG & Co KgaA face in the near future?

Has there been any significant insider trading activity
in SCHOTT Pharma AG & Co KgaA recently?

Summarize the latest earnings call
of SCHOTT Pharma AG & Co KgaA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for SCHOTT Pharma AG & Co KgaA.

Provide P/S
for SCHOTT Pharma AG & Co KgaA.

Provide P/E
for SCHOTT Pharma AG & Co KgaA.

Provide P/OCF
for SCHOTT Pharma AG & Co KgaA.

Provide P/FCFE
for SCHOTT Pharma AG & Co KgaA.

Provide P/B
for SCHOTT Pharma AG & Co KgaA.

Provide EV/S
for SCHOTT Pharma AG & Co KgaA.

Provide EV/GP
for SCHOTT Pharma AG & Co KgaA.

Provide EV/EBITDA
for SCHOTT Pharma AG & Co KgaA.

Provide EV/EBIT
for SCHOTT Pharma AG & Co KgaA.

Provide EV/OCF
for SCHOTT Pharma AG & Co KgaA.

Provide EV/FCFF
for SCHOTT Pharma AG & Co KgaA.

Provide EV/IC
for SCHOTT Pharma AG & Co KgaA.

Show me price targets
for SCHOTT Pharma AG & Co KgaA made by professional analysts.

What are the Revenue projections
for SCHOTT Pharma AG & Co KgaA?

How accurate were the past Revenue estimates
for SCHOTT Pharma AG & Co KgaA?

What are the Net Income projections
for SCHOTT Pharma AG & Co KgaA?

How accurate were the past Net Income estimates
for SCHOTT Pharma AG & Co KgaA?

What are the EPS projections
for SCHOTT Pharma AG & Co KgaA?

How accurate were the past EPS estimates
for SCHOTT Pharma AG & Co KgaA?

What are the EBIT projections
for SCHOTT Pharma AG & Co KgaA?

How accurate were the past EBIT estimates
for SCHOTT Pharma AG & Co KgaA?

Compare the revenue forecasts
for SCHOTT Pharma AG & Co KgaA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of SCHOTT Pharma AG & Co KgaA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of SCHOTT Pharma AG & Co KgaA against its competitors.

Analyze the profit margins
(gross, operating, and net) of SCHOTT Pharma AG & Co KgaA compared to its peers.

Compare the P/E ratios
of SCHOTT Pharma AG & Co KgaA against its peers.

Discuss the investment returns and shareholder value creation
comparing SCHOTT Pharma AG & Co KgaA with its peers.

Analyze the financial leverage
of SCHOTT Pharma AG & Co KgaA compared to its main competitors.

Show all profitability ratios
for SCHOTT Pharma AG & Co KgaA.

Provide ROE
for SCHOTT Pharma AG & Co KgaA.

Provide ROA
for SCHOTT Pharma AG & Co KgaA.

Provide ROIC
for SCHOTT Pharma AG & Co KgaA.

Provide ROCE
for SCHOTT Pharma AG & Co KgaA.

Provide Gross Margin
for SCHOTT Pharma AG & Co KgaA.

Provide Operating Margin
for SCHOTT Pharma AG & Co KgaA.

Provide Net Margin
for SCHOTT Pharma AG & Co KgaA.

Provide FCF Margin
for SCHOTT Pharma AG & Co KgaA.

Show all solvency ratios
for SCHOTT Pharma AG & Co KgaA.

Provide D/E Ratio
for SCHOTT Pharma AG & Co KgaA.

Provide D/A Ratio
for SCHOTT Pharma AG & Co KgaA.

Provide Interest Coverage Ratio
for SCHOTT Pharma AG & Co KgaA.

Provide Altman Z-Score Ratio
for SCHOTT Pharma AG & Co KgaA.

Provide Quick Ratio
for SCHOTT Pharma AG & Co KgaA.

Provide Current Ratio
for SCHOTT Pharma AG & Co KgaA.

Provide Cash Ratio
for SCHOTT Pharma AG & Co KgaA.

What is the historical Revenue growth
over the last 5 years for SCHOTT Pharma AG & Co KgaA?

What is the historical Net Income growth
over the last 5 years for SCHOTT Pharma AG & Co KgaA?

What is the current Free Cash Flow
of SCHOTT Pharma AG & Co KgaA?

Discuss the annual earnings per share (EPS)
trend over the past five years for SCHOTT Pharma AG & Co KgaA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
SCHOTT Pharma AG & Co KgaA

Balance Sheet Decomposition
SCHOTT Pharma AG & Co KgaA

Current Assets 586m
Cash & Short-Term Investments 29.5m
Receivables 380.5m
Other Current Assets 176m
Non-Current Assets 813.1m
Long-Term Investments 84.9m
PP&E 679.7m
Intangibles 30.6m
Other Non-Current Assets 17.9m
Current Liabilities 415.6m
Accounts Payable 91m
Accrued Liabilities 53m
Other Current Liabilities 271.6m
Non-Current Liabilities 215.9m
Long-Term Debt 81.1m
Other Non-Current Liabilities 134.8m
Efficiency

Earnings Waterfall
SCHOTT Pharma AG & Co KgaA

Revenue
948.6m EUR
Cost of Revenue
-624.4m EUR
Gross Profit
324.2m EUR
Operating Expenses
-154.8m EUR
Operating Income
169.4m EUR
Other Expenses
-19m EUR
Net Income
150.4m EUR

Free Cash Flow Analysis
SCHOTT Pharma AG & Co KgaA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

1SXP Profitability Score
Profitability Due Diligence

SCHOTT Pharma AG & Co KgaA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROE
Positive Gross Profit
Positive Operating Income
Positive 3-Year Average ROIC
59/100
Profitability
Score

SCHOTT Pharma AG & Co KgaA's profitability score is 59/100. The higher the profitability score, the more profitable the company is.

1SXP Solvency Score
Solvency Due Diligence

SCHOTT Pharma AG & Co KgaA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
78/100
Solvency
Score

SCHOTT Pharma AG & Co KgaA's solvency score is 78/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

1SXP Price Targets Summary
SCHOTT Pharma AG & Co KgaA

Wall Street analysts forecast 1SXP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 1SXP is 31.8 EUR with a low forecast of 22.22 EUR and a high forecast of 38.85 EUR.

Lowest
Price Target
22.22 EUR
10% Downside
Average
Price Target
31.8 EUR
28% Upside
Highest
Price Target
38.85 EUR
57% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for 1SXP?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 1SXP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

1SXP Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one 1SXP stock?

The intrinsic value of one 1SXP stock under the Base Case scenario is 32.11 EUR.

Is 1SXP stock undervalued or overvalued?

Compared to the current market price of 24.76 EUR, SCHOTT Pharma AG & Co KgaA is Undervalued by 23%.

Back to Top